文献速递重症综合管理与镇静镇痛复苏、休克与脓毒症呼吸衰竭与机械通气

线粒体与危重症

Mitochondria and Critical Illness.
PubMed 文献 · Chest · 2019-09-05
一句话结论线粒体通过调控细胞信号、基因表达、钙稳态和细胞死亡通路影响脓毒症、ICU获得性肌无力、急性肺损伤、急性肾损伤及危重症免疫失调的发生发展。

本文综述线粒体功能与急性危重症之间不断演变的概念。线粒体不仅通过调节细胞代谢和高能磷酸化合物产生速率影响疾病发展,还在细胞信号传导、基因表达调控、细胞钙水平调节及细胞死亡通路激活中起关键作用。这些多重功能特征影响脓毒症、ICU获得性骨骼肌功能障碍、急性肺损伤、急性肾衰竭和危重症相关免疫功能失调等多种疾病状态的细胞和器官功能演变。此外,受损线粒体产生毒性物质,最突出的是释放的线粒体DNA,可作为危险相关分子模式诱导全身毒性并损害全身多个器官。

要点

  • 线粒体功能影响脓毒症、ICU获得性骨骼肌功能障碍、急性肺损伤、急性肾衰竭和危重症相关免疫功能失调的细胞与器官功能演变。
  • 受损线粒体释放的线粒体DNA可作为危险相关分子模式诱导全身毒性并损害全身多个器官。
  • 线粒体通过调控细胞信号、基因表达、细胞钙水平和细胞死亡通路(如caspase激活)影响急性疾病进程。
  • 本文讨论包括线粒体生理学基础、线粒体病理生理的细胞机制、受线粒体病理生理影响的危重症疾病过程及危重症线粒体功能障碍的新兴治疗。

研究设计与关键结果

  • 综述将讨论组织为四部分:线粒体生理学基础;线粒体病理生理的细胞机制;起始和演变受线粒体病理生理影响的危重症疾病过程;危重症线粒体功能障碍的新兴治疗。

证据类型、等级与局限

  • 证据类型:综述。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 原文未据此给出推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「适用人群与场景」「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Classically, mitochondria have largely been believed to influence the development of illness by modulating cell metabolism and determining the rate of production of high-energy phosphate compounds (eg, adenosine triphosphate). It is now recognized that this view is simplistic and that mitochondria play key roles in many other processes, including cell signaling, regulating gene expression, modulating cellular calcium levels, and influencing the activation of cell death pathways (eg, caspase activation). Moreover, these multiple mitochondrial functional characteristics are now known to influence the evolution of cellular and organ function in many disease states, including sepsis, ICU-acquired skeletal muscle dysfunction, acute lung injury, acute renal failure, and critical illness-related immune function dysregulation. In addition, diseased mitochondria generate toxic compounds, most notably released mitochondrial DNA, which can act as danger-associated molecular patterns to induce systemic toxicity and damage multiple organs throughout the body. This article reviews these evolving concepts relating mitochondrial function and acute illness. The discussion is organized into four sections: (1) basics of mitochondrial physiology; (2) cellular mechanisms of mitochondrial pathophysiology; (3) critical care disease processes whose initiation and evolution are shaped by mitochondrial pathophysiology; and (4) emerging treatments for mitochondrial dysfunction in critical illness.

来源:Chest,查看原文。版权归原作者所有。

参考来源

  1. Supinski GS, Schroder EA, Callahan LA, et al. Mitochondria and Critical Illness. Chest. 2019. PMID: 31494084. doi:10.1016/j.chest.2019.08.2182

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。